Qubo Zhu

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

ACS biomaterials science & engineering

Oncogene

Cancers

Critical reviews in biochemistry and molecular biology

Central South University

Texas A&M University health science center (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Central South University Sep 01 2011

China

Associate Professor :: School of Pharmaceutical Science

Education History

Texas A&M University health science center Dec 31 2003 - May 01 2009

United States

PHD :: Institute of Biosciences and Technology

Wuhan University Sep 01 1999 - Jul 01 2003

China

BSC :: College of Life Sciences

Publications

Yuying Hu, Xiangjian Liu, Fenglin Liu, Jingxian Xie, Qubo Zhu, Songwen Tan
Trehalose in Biomedical Cryopreservation-Properties, Mechanisms, Delivery Methods, Applications, Benefits, and Problems. ACS biomaterials science & engineering (2023)
Ying Huang, Haofei Ji, Jiani Dong, Xueying Wang, Zhilin He, Zeneng Cheng, Qubo Zhu
CPSF3 Promotes Pre-mRNA Splicing and Prevents CircRNA Cyclization in Hepatocellular Carcinoma. Cancers 15 (16) (2023)
Jiani Dong, Zhuoer Zeng, Ying Huang, Chuanpin Chen, Zeneng Cheng, Qubo Zhu
Challenges and opportunities for circRNA identification and delivery. Critical reviews in biochemistry and molecular biology (2023)
Yuying Hu, Xiangjian Liu, Fenglin Liu, Jingxian Xie, Qubo Zhu, Songwen Tan
Trehalose in Biomedical Cryopreservation-Properties, Mechanisms, Delivery Methods, Applications, Benefits, and Problems. ACS biomaterials science & engineering 9 (3) (2023)
Yuying Hu, Xiangjian Liu, Fenglin Liu, Jingxian Xie, Qubo Zhu, Songwen Tan
Trehalose in Biomedical Cryopreservation-Properties, Mechanisms, Delivery Methods, Applications, Benefits, and Problems. ACS biomaterials science & engineering 9 (3) (2023)
Ying Huang, Qubo Zhu
Mechanisms Regulating Abnormal Circular RNA Biogenesis in Cancer. Cancers 13 (16) (2021)
Qin Ouyang, Yingcai Meng, Wenhu Zhou, Jianbin Tong, Zeneng Cheng, Qubo Zhu
New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease. Journal of drug targeting (2021)
Yue Su, Bolun Zhang, Ruowei Sun, Wenfang Liu, Qubo Zhu, Xun Zhang, Rongrong Wang, Chuanpin Chen
PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application. Drug delivery 28 (1) (2021)
Xueying Wang, Jiani Dong, Xiaojing Li, Zeneng Cheng, Qubo Zhu
CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma. Oncogene 40 (25) (2021)
Xiaojing Li, Xueying Wang, Zeneng Cheng, Qubo Zhu
AGO2 and its partners: a silencing complex, a chromatin modulator, and new features. Critical reviews in biochemistry and molecular biology 55 (1) (2020)
Jiani Dong, Zeneng Cheng, Songwen Tan, Qubo Zhu
Clay nanoparticles as pharmaceutical carriers in drug delivery systems. Expert opinion on drug delivery 18 (6) (2020)
Xiaojing Li, Junyao Ding, Xueying Wang, Zeneng Cheng, Qubo Zhu
NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma. Oncogene 39 (4) (2019)
Junyao Ding, Wenhu Zhou, Xiaojing Li, Meng Sun, Jingsong Ding, Qubo Zhu
Tandem DNAzyme for double digestion: a new tool for circRNA suppression. Biological chemistry 400 (2) (2019)

Qubo Zhu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Qubo Zhu